The synthesis and fluorescence profile of novel thalidomide analogues
Authors:
- Sven S. KampmannSKSven S. Kampmann
- Brian W. SkeltonBSBrian W. Skelton
- George C. YeohGYGeorge C. Yeoh
- Lawrence J. AbrahamLALawrence J. Abraham
- Nigel A. LengkeekNLNigel A. Lengkeek
- Keith A. StubbsKSKeith A. Stubbs
- Charles H. HeathCHCharles H. Heath
- Scott G. StewartSSScott G. Stewart
- 1 October 2015
- journal article
- Published by Elsevier in Tetrahedron
- Vol. 71 (42) , 8140-8149
Abstract
No abstract availableKeywords
Funding Information
- Cancer Council of WA (1041468)
- Institute of Nuclear Science and Engineering (ALNGRA12073)
- Australian Research Council (FT100100291)
This publication has 25 references indexed in Scilit:
- Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogsNature Structural & Molecular Biology, 2014
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomideNature, 2014
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomideLeukemia, 2012
- Novel thalidomide analogues with potent NFκB and TNF expression inhibitionMedChemComm, 2011
- Teratogenic effects of thalidomide: molecular mechanismsCellular and Molecular Life Sciences, 2011
- Efforts toward elucidating Thalidomide’s molecular target: an expedient synthesis of the first Thalidomide biotin analogueOrganic & Biomolecular Chemistry, 2010
- Identification of a Primary Target of Thalidomide TeratogenicityScience, 2010
- New thalidomide analogues derived through Sonogashira or Suzuki reactions and their TNF expression inhibition profilesBioorganic & Medicinal Chemistry, 2010
- Synthesis and TNF expression inhibitory properties of new thalidomide analogues derived via Heck cross couplingBioorganic & Medicinal Chemistry Letters, 2007
- The evolution of thalidomide and its IMiD derivatives as anticancer agentsNature Reviews Cancer, 2004